Literature DB >> 21546047

Autosomal dominant cerebellar ataxias.

C Marelli1, C Cazeneuve, A Brice, G Stevanin, A Dürr.   

Abstract

Cerebellar ataxias with autosomal dominant transmission (ADCA) are far rarer than sporadic cases of cerebellar ataxia. The identification of genes involved in dominant forms has confirmed the genetic heterogeneity of these conditions and of the underlying mechanisms and pathways. To date, at least 28 genetic loci and, among them, 20 genes have been identified. In many instances, the phenotype is not restricted to cerebellar dysfunction but includes more complex multisystemic neurological deficits. Seven ADCA (SCA1, 2, 3, 6, 7, 17, and dentatorubro-pallido-luysian atrophy) are caused by repeat expansions in the corresponding proteins; phenotype-genotype correlations have shown that repeat size influences the progression of the disease, its severity and clinical differences among patients, including the phenomenon of anticipation between generations. All other ADCA are caused either by non-coding repeat expansions, conventional mutations or large rearrangements in genes with different functions. This review will focus on the genetic features of ADCA and on the clinical differences among the different forms.
Copyright © 2011. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2011        PMID: 21546047     DOI: 10.1016/j.neurol.2011.01.015

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  2 in total

1.  Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia.

Authors:  Xiaofei Du; Joao L Carvalho-de-Souza; Cenfu Wei; Willy Carrasquel-Ursulaez; Yenisleidy Lorenzo; Naileth Gonzalez; Tomoya Kubota; Julia Staisch; Timothy Hain; Natalie Petrossian; Michael Xu; Ramon Latorre; Francisco Bezanilla; Christopher M Gomez
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-04       Impact factor: 11.205

2.  The frequency of spinocerebellar ataxia type 23 in a UK population.

Authors:  Katherine Fawcett; Mohadeseh Mehrabian; Yo-Tsen Liu; Sherifa Hamed; Elahe Elahi; Tamas Revesz; Georgios Koutsis; Joshua Herscheson; Lucia Schottlaender; Mark Wardle; Patrick J Morrison; Huw R Morris; Paola Giunti; Nicholas Wood; Henry Houlden
Journal:  J Neurol       Date:  2012-10-30       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.